DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Wei A, Strickland S, Roboz G. et al.
Safety and efficacy of venetoclax plus low-dose cytarabine in treatment-naive patients aged ≥65 years with acute myeloid leukemia. Proceedings from the 2016 annual meeting of the American Society of Hematology (ASH).
Blood 2016;
128: Abstract 102
We do not assume any responsibility for the contents of the web pages of other providers.